One Patient's Complete Response to Investigational Cancer Therapy Sparks Hope (BPT) - Werewolf Therapeutics' clinical trials are underway and they're already changing lives.
Top movers in Tuesday's after hours session Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
HOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Beats Revenue for Q2 2024 HOWL stock results show that Werewolf Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
HOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Misses Revenue for Q1 2024 HOWL stock results show that Werewolf Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
HOWL Stock Earnings: Werewolf Therapeutics Beats EPS, Misses Revenue for Q4 2023 HOWL stock results show that Werewolf Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Top 5 Health Care Stocks That May Fall Off A Cliff This Month The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Delta Air Lines Layoffs 2023: What to Know About the Latest DAL Job Cuts Delta Air Lines layoffs have the air travel company announcing minor adjustments to its corporate and management positions.
CVNA Stock Alert: What Analysts Are Saying After Carvana’s Q3 Earnings Carvana stock is on the move as analysts weigh in on CVNA shares following the release of the company's latest earnings report.
Why Is Werewolf Therapeutics (HOWL) Stock Up 20% Today? Werewolf Therapeutics stock is taking off with heavy trading of HOWL shares after posting preliminary data from a clinical trial.
Werewolf Therapeutics' Cancer Drug Shows Promise in Early Study for Solid Tumors, Stock Soars Werewolf Therapeutics Inc (
NASDAQ: HOWL ) released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or
Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket Gainers LumiraDx Limited (
NASDAQ: LMDX ) shares surged 39.7% to $0.1143 in pre-market trading after falling 17% on Wednesday. LumiraDX recently announced the receipt of the Nasdaq delisting determination.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday Pre-market stock movers are a hot topic on Thursday and we're checking out all of the biggest ones worth watching this morning!
